TLE4 Activators
The chemical class identified as TLE4 activators encompasses a diverse array of compounds that intricately modulate TLE4 activation through direct or indirect mechanisms. Histone deacetylase inhibitors, such as Trichostatin A and Sodium Butyrate, directly impact TLE4 activation by promoting histone acetylation, creating a permissive chromatin environment for enhanced TLE4 gene transcription. Furthermore, indirect TLE4 activation is achieved through the modulation of various cellular pathways. Compounds like Resveratrol and BAY 11-7082 influence TLE4 through SIRT1 activation and NF-κB inhibition, respectively. These compounds showcase the intricate network of pathways converging on TLE4 activation, illustrating the multifaceted regulatory mechanisms governing its expression.
In addition, the class includes inhibitors targeting specific cellular processes. For instance, C646, a p300/CBP histone acetyltransferase inhibitor, alters histone acetylation dynamics, influencing TLE4 gene transcription. PD0325901, a MEK inhibitor, indirectly activates TLE4 by affecting the MAPK/ERK signaling pathway, showcasing the interplay between kinase activities and TLE4 regulation. In conclusion, the chemical class of TLE4 activators comprises compounds that either directly promote histone acetylation or indirectly modulate cellular pathways, leading to enhanced TLE4 gene expression. Understanding the intricate regulatory network controlled by these chemicals provides valuable insights into the molecular mechanisms governing TLE4 activation in cellular processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a short-chain fatty acid, is known for its histone deacetylase (HDAC) inhibitory activity. It can indirectly activate TLE4 by promoting histone acetylation, leading to changes in chromatin structure and facilitating TLE4 gene transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenol found in red grapes, acts as an indirect TLE4 activator by modulating the SIRT1 pathway. Through activation of SIRT1, resveratrol influences histone deacetylation, creating an environment that supports TLE4 gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, can indirectly activate TLE4 by affecting the p38 MAPK signaling pathway. Inhibition of p38 MAPK alters the cellular context, potentially influencing TLE4 activation through changes in downstream signaling cascades. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646, a p300/CBP histone acetyltransferase inhibitor, indirectly activates TLE4 by modulating the p300/CBP pathway. Inhibition of p300/CBP alters histone acetylation dynamics, influencing TLE4 gene transcription and activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, can indirectly activate TLE4 by modulating the PI3K/Akt signaling pathway. Inhibition of PI3K alters the cellular environment, potentially influencing TLE4 activation through changes in downstream signaling cascades. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, indirectly activates TLE4 by affecting DNA methylation patterns. By inhibiting DNA methyltransferase, 5-Azacytidine alters the epigenetic landscape, potentially influencing TLE4 gene expression and activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an HDAC inhibitor, directly impacts TLE4 activation by promoting histone acetylation. Through epigenetic modifications, Trichostatin A facilitates a permissive chromatin environment, allowing for enhanced TLE4 gene transcription. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, an NF-κB inhibitor, indirectly activates TLE4 by modulating the NF-κB signaling pathway. Inhibition of NF-κB alters the cellular context, potentially influencing TLE4 activation through changes in downstream signaling cascades. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638, a G9a/GLP histone methyltransferase inhibitor, indirectly activates TLE4 by affecting histone methylation patterns. Inhibition of G9a/GLP alters the epigenetic landscape, potentially influencing TLE4 gene expression and activation. | ||||||
A-485 | 1889279-16-6 | sc-507493 | 5 mg | $275.00 | ||
A-485, a selective p300/CBP histone acetyltransferase inhibitor, indirectly activates TLE4 by modulating the p300/CBP pathway. Inhibition of p300/CBP alters histone acetylation dynamics, influencing TLE4 gene transcription and activation. | ||||||